Effects of Apixaban Compared With Warfarin as Gain in Event-Free Time – A Novel Assessment of the Results of the ARISTOTLE Trial

European Journal of Preventive Cardiology - United Kingdom
doi 10.1177/2047487319886959
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

The Cost-Effectiveness of Apixaban Compared to Warfarin, Aspirin, Rivaroxaban and Dabigatran in Ireland

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

The Efficacy and Safety of Apixaban Versus Warfarin Are Preserved in Patients With Atrial Fibrillation and Extreme Body Weight: Insights From the Aristotle Study

Canadian Journal of Cardiology
Cardiovascular MedicineCardiology
2018English

Cost-Effectiveness of Apixaban Compared With Aspirin for Stroke Prevention in Atrial Fibrillation Among Patients Unsuitable for Warfarin

Circulation. Cardiovascular quality and outcomes
MedicineCardiovascular MedicineCardiology
2012English

Cost-Effectiveness of Apixaban Compared to Other Anticoagulants in Patients With Atrial Fibrillation in the Real-World and Trial Settings

PLoS ONE
Multidisciplinary
2019English

High-Sensitivity Troponin I for Risk Assessment in Patients With Atrial Fibrillation: Insights From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2014English

Assessment of the Anticoagulation Activity of Apixaban – Reply –

Circulation Journal
MedicineCardiovascular MedicineCardiology
2015English

Laboratory Assessment of the Anticoagulant Activity of Apixaban in Patients With Nonvalvular Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2018English

Dabigatran Compared With Rivaroxaban vs Warfarin

JAMA Internal Medicine
Internal Medicine
2017English

Response to Letters Regarding Article, "Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin: Results From the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Randomized Trial"

Circulation
Cardiovascular MedicinePhysiologyCardiology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy